bucladesine and ru 42173

bucladesine has been researched along with ru 42173 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Doornbos, RP; Rodenburg, RJ; van der Greef, J; Verhoeckx, KC; Witkamp, RF	1

Other Studies

1 other study(ies) available for bucladesine and ru 42173

Article	Year
Beta-adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M, and vascular endothelial growth factor from macrophages. International immunopharmacology, 2006, Volume: 6, Issue:1 Topics: Adrenergic beta-Agonists; Bucladesine; Chemokine CXCL6; Chemokines, CXC; Clenbuterol; Colforsin; Cyclic AMP; Cytokines; Dinoprostone; Humans; Lipopolysaccharides; Macrophage Activation; Macrophages; Oncostatin M; Trimethylsilyl Compounds; U937 Cells; Up-Regulation; Vascular Endothelial Growth Factor A	2006

Article

Year

Beta-adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M, and vascular endothelial growth factor from macrophages.

International immunopharmacology, 2006, Volume: 6, Issue:1

Topics: Adrenergic beta-Agonists; Bucladesine; Chemokine CXCL6; Chemokines, CXC; Clenbuterol; Colforsin; Cyclic AMP; Cytokines; Dinoprostone; Humans; Lipopolysaccharides; Macrophage Activation; Macrophages; Oncostatin M; Trimethylsilyl Compounds; U937 Cells; Up-Regulation; Vascular Endothelial Growth Factor A

2006